Microbiome factors in HPV-driven carcinogenesis and cancers
Autoři:
Daniel Lin aff001; Ramez Kouzy aff001; Joseph Abi Jaoude aff001; Sonal S. Noticewala aff001; Andrea Y. Delgado Medrano aff001; Ann H. Klopp aff001; Cullen M. Taniguchi aff001; Lauren E. Colbert aff001
Působiště autorů:
Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
aff001
Vyšlo v časopise:
Microbiome factors in HPV-driven carcinogenesis and cancers. PLoS Pathog 16(6): e1008524. doi:10.1371/journal.ppat.1008524
Kategorie:
Pearls
doi:
https://doi.org/10.1371/journal.ppat.1008524
Zdroje
1. Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer J Int Cancer. 2012;131: 1969–1982. doi: 10.1002/ijc.27650 22623137
2. Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primer. 2016;2: 16086. doi: 10.1038/nrdp.2016.86 27905473
3. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF. Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression. Münger K, editor. PLoS Pathog. 2009;5: e1000318. doi: 10.1371/journal.ppat.1000318 19247434
4. FERNANDES JV, DE MEDEIROS FERNANDES TAA, DE AZEVEDO JCV, COBUCCI RNO, DE CARVALHO MGF, ANDRADE VS, et al. Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review). Oncol Lett. 2015;9: 1015–1026. doi: 10.3892/ol.2015.2884 25663851
5. Chang AH, Parsonnet J. Role of Bacteria in Oncogenesis. Clin Microbiol Rev. 2010;23: 837–857. doi: 10.1128/CMR.00012-10 20930075
6. D’Amore R, Ijaz UZ, Schirmer M, Kenny JG, Gregory R, Darby AC, et al. A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling. BMC Genomics. 2016;17: 55. doi: 10.1186/s12864-015-2194-9 26763898
7. Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun. 2016;469: 967–977. doi: 10.1016/j.bbrc.2015.12.083 26718401
8. Guijon F, Paraskevas M, Rand F, Heywood E, Brunham R, McNicol P. Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia. Int J Gynecol Obstet. 1992;37: 185–191. doi: 10.1016/0020-7292(92)90379-W
9. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci. 2011;108: 4680–4687. doi: 10.1073/pnas.1002611107 20534435
10. Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep. 2015;5: 16865. doi: 10.1038/srep16865 26574055
11. Piyathilake CJ, Ollberding NJ, Kumar R, Macaluso M, Alvarez RD, Morrow CD. Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses. Cancer Prev Res Phila Pa. 2016;9: 357–366. doi: 10.1158/1940-6207.CAPR-15-0350 26935422
12. Audirac-Chalifour A, Torres-Poveda K, Bahena-Román M, Téllez-Sosa J, Martínez-Barnetche J, Cortina-Ceballos B, et al. Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. Tornesello ML, editor. PLoS ONE. 2016;11: e0153274. doi: 10.1371/journal.pone.0153274 27115350
13. Klein C, Gonzalez D, Samwel K, Kahesa C, Mwaiselage J, Aluthge N, et al. Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions. mBio. 2019;10: e02785–18. doi: 10.1128/mBio.02785-18 30782659
14. Łaniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, et al. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 2018;8: 7593. doi: 10.1038/s41598-018-25879-7 29765068
15. Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4: 58. doi: 10.1186/s40168-016-0203-0 27802830
16. Macklaim JM, Gloor GB, Anukam KC, Cribby S, Reid G. At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci. 2011;108: 4688–4695. doi: 10.1073/pnas.1000086107 21059957
17. Gillet E, Meys JFA, Verstraelen H, Verhelst R, De Sutter P, Temmerman M, et al. Association between Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Systematic Review and Meta-Analysis. PLoS ONE. 2012;7: e45201. doi: 10.1371/journal.pone.0045201 23056195
18. Mitchell C, Marrazzo J. Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol N Y N 1989. 2014;71: 555–563. doi: 10.1111/aji.12264 24832618
19. Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis. Microorganisms. 2019;7: E199. doi: 10.3390/microorganisms7070199 31337018
20. Mackelprang RD, Scoville CW, Cohen CR, Ondondo RO, Bigham AW, Celum C, et al. Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women. Genes Immun. 2015;16: 362–365. doi: 10.1038/gene.2015.13 25928881
21. Kwon M, Seo S-S, Kim M, Lee D, Lim M. Compositional and Functional Differences between Microbiota and Cervical Carcinogenesis as Identified by Shotgun Metagenomic Sequencing. Cancers. 2019;11: 309. doi: 10.3390/cancers11030309 30841606
22. Wang Z, Wang Q, Zhao J, Gong L, Zhang Y, Wang X, et al. Altered diversity and composition of the gut microbiome in patients with cervical cancer. AMB Express. 2019;9: 40. doi: 10.1186/s13568-019-0763-z 30904962
23. Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, et al. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. 2019;155(2):237–244. doi: 10.1016/j.ygyno.2019.09.002 31500892
24. Colbert LE, Delgado Medrano AY, Mikkelson MD, Previs R, Eifel PJ, Jhingran A, et al. Clonal Expansion of Antigen Specific T-Cells during Radiation Therapy for HPV Associated Cervical Cancers Is Regulated By the Vaginal Microbiome. Int J Radiat Oncol. 2018;102: S24. doi: 10.1016/j.ijrobp.2018.06.145
25. Mitchell C, Fredricks D, Agnew K, Hitti J. Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis. Sex Transm Dis. 2015;42: 358–363. doi: 10.1097/OLQ.0000000000000298 26222747
26. Guerrero-Preston R, Godoy-Vitorino F, Jedlicka A, Rodríguez-Hilario A, González H, Bondy J, et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget. 2016;7: 51320–51334. doi: 10.18632/oncotarget.9710 27259999
27. Zaura E, Keijser BJ, Huse SM, Crielaard W. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol. 2009;9: 259. doi: 10.1186/1471-2180-9-259 20003481
28. Lim Y, Fukuma N, Totsika M, Kenny L, Morrison M, Punyadeera C. The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers. Front Cell Infect Microbiol. 2018;8: 267. doi: 10.3389/fcimb.2018.00267 30123780
29. Guerrero-Preston R, White JR, Godoy-Vitorino F, Rodríguez-Hilario A, Navarro K, González H, et al. High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. Oncotarget. 2017;8: 110931–110948. doi: 10.18632/oncotarget.20677 29340028
30. Ogilvie LA, Jones BV. The human gut virome: a multifaceted majority. Front Microbiol. 2015;6: 918. doi: 10.3389/fmicb.2015.00918 26441861
31. Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574: 264–267. doi: 10.1038/s41586-019-1608-2 31578522
32. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment. Science. 2013;342: 967–970. doi: 10.1126/science.1240527 24264989
33. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science. 2018;359: 97–103. doi: 10.1126/science.aan4236 29097493
Článek vyšel v časopise
PLOS Pathogens
2020 Číslo 6
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Ibuprofen jako alternativa antibiotik při léčbě infekcí močových cest
- Infekce se v Americe po příjezdu Kolumba šířily nesrovnatelně déle, než se traduje
Nejčtenější v tomto čísle
- Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis
- Microbiome factors in HPV-driven carcinogenesis and cancers
- Biological sex impacts COVID-19 outcomes
- Bacterial killing by complement requires direct anchoring of membrane attack complex precursor C5b-7